Maternal Vaccination Not Tied to Infant Hospitalization, Death
TUESDAY, Feb. 20, 2018 -- Maternal receipt of influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines is not associated with infant hospitalization or death in the first six months of life, according to a study published online Feb. 20 in Pediatrics.
Lakshmi Sukumaran, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the correlation between maternal receipt of influenza and Tdap vaccines and the risk of infant hospitalization or death. Singleton, live-birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 were included.
The researchers identified 413,034 live births in the population. In the first six months of life, 25,222 infants had hospitalizations and 157 infants died. There was no correlation between infant hospitalization and maternal influenza (adjusted odds ratio, 1; 95 percent confidence interval, 0.96 to 1.04) or Tdap (adjusted odds ratio, 0.94; 95 percent confidence interval, 0.88 to 1.01) vaccinations. No correlation was identified between infant mortality and maternal influenza (adjusted odds ratio, 0.96; 95 percent confidence interval, 0.54 to 1.69) or Tdap (adjusted odds ratio, 0.44; 95 percent confidence interval, 0.17 to 1.13) vaccinations.
"These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy," the authors write.
Two authors disclosed financial ties to the pharmaceutical industry.
© 2020 HealthDay. All rights reserved.
Posted: February 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.